1. Home
  2. CPIX vs MCHX Comparison

CPIX vs MCHX Comparison

Compare CPIX & MCHX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cumberland Pharmaceuticals Inc.

CPIX

Cumberland Pharmaceuticals Inc.

HOLD

Current Price

$3.18

Market Cap

73.6M

Sector

Health Care

ML Signal

HOLD

Logo Marchex Inc. Class B

MCHX

Marchex Inc. Class B

HOLD

Current Price

$1.51

Market Cap

66.3M

ML Signal

HOLD

Company Overview

Basic Information
Metric
CPIX
MCHX
Founded
1999
2003
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
73.6M
66.3M
IPO Year
2007
2003

Fundamental Metrics

Financial Performance
Metric
CPIX
MCHX
Price
$3.18
$1.51
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
95.4K
12.0K
Earning Date
03-03-2026
03-25-2026
Dividend Yield
N/A
N/A
EPS Growth
58.70
N/A
EPS
N/A
N/A
Revenue
$42,010,949.00
$90,291,000.00
Revenue This Year
N/A
$9.12
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
16.75
N/A
52 Week Low
$1.85
$1.26
52 Week High
$6.27
$2.30

Technical Indicators

Market Signals
Indicator
CPIX
MCHX
Relative Strength Index (RSI) 46.32 57.39
Support Level $2.95 $1.35
Resistance Level $3.69 $1.60
Average True Range (ATR) 0.23 0.09
MACD 0.04 0.02
Stochastic Oscillator 75.00 85.79

Price Performance

Historical Comparison
CPIX
MCHX

About CPIX Cumberland Pharmaceuticals Inc.

Cumberland Pharmaceuticals Inc is a specialty pharmaceutical company focused on the acquisition, development, and commercialization of branded prescription pharmaceutical products. The Company has one operating segment which is specialty pharmaceutical products. The company's target markets are hospital acute care, gastroenterology, rheumatology, and oncology. The company promotes its approved products through its hospital, field, and oncology sales divisions in the United States and establishes a network of international partners to register and provide medicines to patients in their countries. The company's revenue is derived from the product sales of FDA-approved pharmaceutical brands. Its brands include Acetadote, Caldolor, Kristalose, Omeclamox, Sancuso, Vaprisol and Vibativ.

About MCHX Marchex Inc. Class B

Marchex Inc provides AI-based conversational intelligence and analytics solutions that generate insights from customer communications data. The company's products support sales, marketing, and executive teams in analyzing customer interactions across communication channels and informing business decisions. It serves companies operating in business-to-business-to-consumer (B2B2C) markets across multiple industries like automotive, home services, healthcare, real estate, and advertising. The company operates in a single segment: conversational analytics and related solutions. The company generates the majority of revenue from its conversational intelligence product offerings. Geographically, it generates the maximum revenue from the United States.

Share on Social Networks: